3,514
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A Risk Prediction Model of DNA Methylation Improves Prognosis Evaluation and Indicates Gene Targets in Prostate Cancer

ORCID Icon, , , &
Pages 333-352 | Received 19 Nov 2019, Accepted 21 Jan 2020, Published online: 06 Feb 2020

References

  • Siegel RL , MillerKD , JemalA. Cancer statistics, 2018. CA Cancer J. Clin.68(1), 7–30 (2018).
  • Eggener SE , CifuAS , NabhanC. Prostate cancer screening. JAMA314(8), 825–826 (2015).
  • Hayes JH , BarryMJ. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA311(11), 1143–1149 (2014).
  • Cooperberg MR , BroeringJM , CarrollPR. Time trends and local variation in primary treatment of localized prostate cancer. J. Clin. Oncol.28(7), 1117–1123 (2010).
  • D’amico AV , WhittingtonR , MalkowiczSBet al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA280(11), 969–974 (1998).
  • Zumsteg ZS , SprattDE , PeiIet al. A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy. Eur. Urol.64(6), 895–902 (2013).
  • Kulis M , EstellerM. DNA methylation and cancer. Adv. Genet.70, 27–56 (2010).
  • Moore LD , LeT , FanG. DNA methylation and its basic function. Neuropsychopharmacology38(1), 23–38 (2013).
  • Costa FF , PaixãoVA , CavalherFPet al. SATR-1 hypomethylation is a common and early event in breast cancer. Cancer Genet. Cytogenet.165(2), 135–143 (2006).
  • Piña IC , GautschiJT , WangGYet al. Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase. J. Org. Chem.68(10), 3866–3873 (2003).
  • Klutstein M , NejmanD , GreenfieldR , CedarH. DNA methylation in cancer and aging. Cancer Res.76(12), 3446–3450 (2016).
  • Mikeska T , CraigJM. DNA methylation biomarkers: cancer and beyond. Genes5(3), 821–864 (2014).
  • Crujeiras AB , Diaz-LagaresA , SandovalJet al. DNA methylation map in circulating leukocytes mirrors subcutaneous adipose tissue methylation pattern: a genome-wide analysis from non-obese and obese patients. Sci.Rep.7, 41903 (2017).
  • Williams C , LewseyJD , BriggsAH , MackayDF. Cost-effectiveness analysis in r using a multi-state modeling survival analysis framework: a tutorial. Med. Decis. Making37(4), 340–352 (2017).
  • George B , SealsS , AbanI. Survival analysis and regression models. J. Nucl. Cardiol.21(4), 686–694 (2014).
  • Svane AM , SoerensenM , LundJet al. DNA methylation and all-cause mortality in middle-aged and elderly danish twins. Genes9(2), E72 (2018).
  • Butcher LM , BeckS. Probe Lasso: a novel method to rope in differentially methylated regions with 450K DNA methylation data. Methods72, 21–28 (2015).
  • Song Q , ShangJ , YangZet al. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma. J. Transl. Med.17(1), 70 (2019).
  • Bertocci MA , BebkoG , VersaceAet al. Reward-related neural activity and structure predict future substance use in dysregulated youth. Psychol. Med.47(8), 1357–1369 (2017).
  • Kuhn M . The caret package. R Foundation for Statistical ComputingVienna, Austria (2012). https://cran.r-project.org/package=caret
  • Treviño V , Tamez-PenaJ. VALORATE: fast and accurate log-rank test in balanced and unbalanced comparisons of survival curves and cancer genomics. Bioinformatics33(12), 1900–1901 (2017).
  • Uusitalo E , RantanenM , KallionpääRAet al. Distinctive cancer associations in patients with neurofibromatosis type 1. J. Clin. Oncol.34(17), 1978–1986 (2016).
  • Emura T , MatsuiS , ChenHY. compound.Cox: univariate feature selection and compound covariate for predicting survival. Comput. Methods Programs Biomed.168, 21–37 (2019).
  • Cao B , ZhangL , ZouYet al. Survival analysis and prognostic nomogram model for multiple system atrophy. Parkinsonism Relat. Disord.54, 68–73 (2018).
  • Blanche P , DartiguesJF , Jacqmin-GaddaH. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med.32(30), 5381–5397 (2013).
  • Love MI , HuberW , AndersS. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.15(12), 550 (2014).
  • Langfelder P , HorvathS. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics9, 559 (2008).
  • Maertens A , TranV , KleensangA , HartungTet al. Weighted gene correlation network analysis (WGCNA) reveals novel transcription factors associated with bisphenol a dose-response. Front. Genet.9, 508 (2018).
  • Horvath S , DongJ. Geometric interpretation of gene coexpression network analysis. PLoS Comput. Biol.4(8), e1000117 (2008).
  • Zhou Y , ZhouB , PacheLet al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun.10(1), 1523 (2019).
  • Tang Z , LiC , KangB , GaoG , LiC , ZhangZ. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res.45(W1), W98–W102 (2017).
  • Lonsdale J , ThomasJ , SalvatoreMet al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet.45(6), 580–585 (2013).
  • Human genomics . The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science348(6235), 648–660 (2015).
  • Ghosh K , ChatterjeeB , MaheswariU , AthifaM , KanadeSR. 4-Nonylphenol-enhanced EZH2 and RNF2 expression, H3K27me3 and H2AK119ub1 marks resulting in silencing of p21CDKN1A in vitro. Epigenomics11(8), 899–916 (2019).
  • Wang Y , ZengL , LiangCet al. Integrated analysis of transcriptome-wide m6A methylome of osteosarcoma stem cells enriched by chemotherapy. Epigenomics11(15), 1693–1715 (2019).
  • Zhang J , ShiK , HuangWet al. The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma. Cancer Cell Int.19, 107 (2019).
  • Royston P , ParmarMK , AltmanDG. Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plots. J. Natl Cancer Inst.100(2), 92–97 (2008).
  • Liu X , HuAX , ZhaoJL , ChenFL. Identification of key gene modules in human osteosarcoma by co-expression analysis weighted gene co-expression network analysis (WGCNA). J. Cell. Biochem.118(11), 3953–3959 (2017).
  • Ravasz E , SomeraAL , MongruDA , OltvaiZN , BarabásiAL. Hierarchical organization of modularity in metabolic networks. Science297(5586), 1551–1555 (2002).
  • Yip AM , HorvathS. Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinformatics8, 22 (2007).
  • Aleksic T , GrayN , WuXet al. Nuclear IGF1R interacts with regulatory regions of chromatin to promote RNA polymerase II recruitment and gene expression associated with advanced tumor stage. Cancer Res.78(13), 3497–3509 (2018).
  • Jia X , ChenJ , SunSet al. Detection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry. Proteomics16(23), 2989–2996 (2016).
  • Komoroski RA , HolderJC , PappasAA , FinkbeinerAE. 31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia. Magn. Reson. Med.65(4), 911–913 (2011).
  • Fahrenholtz CD , GreeneAM , BeltranPJ , BurnsteinKL. A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells. Oncotarget5(19), 9007–9021 (2014).
  • Aly A , MullinsCD , HussainA. Understanding heterogeneity of treatment effect in prostate cancer. Curr. Opin. Oncol.27(3), 209–216 (2015).
  • Wang X , WangD , ZhangH , FengM , WuX. Genome-wide analysis of DNA methylation identifies two CpG sites for the early screening of colorectal cancer. Epigenomics12(1), 37–52 (2019)
  • Murphy K , MurphyBT , BoyceSet al. Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer. Mol. Oncol.12(9), 1513–1525 (2018).
  • Jeyapala R , KamdarS , Olkhov-MitselEet al. An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patients. Urol. Oncol.38(2), 39.e1–39.e9 (2019).
  • Vainio P , GuptaS , KetolaKet al. Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer. Am. J. Pathol.178(2), 525–536 (2011).
  • Vainio P , LehtinenL , MirttiTet al. Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins. Oncotarget2(12), 1176–1190 (2011).
  • Christian PA , FiandaloMV , SchwarzeSR. Possible role of death receptor-mediated apoptosis by the E3 ubiquitin ligases Siah2 and POSH. Mol. Cancer10, 57 (2011).
  • Van Der Heul-Nieuwenhuijsen L , DitsNF , JensterG. Gene expression of forkhead transcription factors in the normal and diseased human prostate. BJU Int.103(11), 1574–1580 (2009).
  • Xin Z , ZhangY , JiangZet al. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate. Hum. Pathol.79, 151–159 (2018).